NatiVita
Manufacturing · Slovakia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Mostová 2, Bratislava, 811 02, SlovakiaPhone Number
+421 918670805Website
www.nativita.comRevenue
<$5 MillionIndustry
About NatiVita
NatiVita Org Chart
Is NatiVita your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when NatiVita launches new products
NatiVita, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if NatiVita has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at NatiVita
Click to see if NatiVita had a recent Job posting/layoffs
Earning: See what the market has to say on NatiVita recently announced quarterly report
Check out if NatiVita is spiking on competitors!
Funding: Get notified immidiatlly once NatiVita has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
NatiVita is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NatiVita is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NatiVita.
NatiVita Tech Stack
A closer look at the technologies used by NatiVita
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NatiVita
NatiVita is an international research and manufacturing pharmaceutical company, it is situated in Beshankovichy urban settlement, Vitebsk region, Belarus. NatiVita is the first company in Belarus, that started developing and producing biopharmaceutical medicines based on monoclonal antibodies using target cell therapy for specific genetic diseases... Read More